Advancing anti-PR3 detection with a novel ELISA generation
Clinical performance of a new, high-sensitivity generation test for anti-PR3 detection.
- PR3 is a key biomarker in ANCA-associated vasculitis, supporting diagnostic evaluation, particularly in Granulomatosis with Polyangiitis.
- Assay performance matters: High-sensitivity ELISA technology offers a reliable approach to determine anti-PR3-specific antibodies and their clinical relevance
- Discover the evidence: explore the study findings and download the full paper to learn more about the clinical performance of anti-PR3 hs ELISA.
Test associated with this resource
Related instruments
Any assay, any sample, any time!
Discover more resources on Vasculitis
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.